摘要
目的:探讨氟桂利嗪联合泰必利治疗偏头痛的临床疗效。方法:将2011年6月-2013年10月本院收诊的60例偏头痛患者随机分成对照组和治疗组各30例,对照组采用氟桂利嗪治疗,治疗组采用氟桂利嗪联合泰必利治疗。治疗前后对两组患者的症状进行量化评分,比较组间疗效差异。结果:治疗2个月后,治疗组痊愈率显著高于对照组,无效率显著低于对照组,两组比较差异有统计学意义(P<0.05);治疗组总有效率为90.0%,显著高于对照组的73.3%,两组比较差异有统计学意义(P<0.05)。治疗2个月后治疗组疼痛程度、头痛发作次数、持续时间均显著低于对照组,两组比较差异有统计学意义(P<0.05)。结论:氟桂利嗪联合泰必利治疗偏头痛能有效改善偏头痛症状,疗效优于单用氟桂利嗪。
Objective：To investigate the clinical efficacy of Flunarizine combined with Tiapride for the patients with migraine.Method：60 patients with migraine in our hospital from June 2011 to October 2013 were randomly divided into the control group（Flunarizine treatment group）of 30 cases and treatment group（Flunarizine combined with Tiapride group）of 30 cases, then the quantify symptom score of two group before the treatment and after the treatment were compared, The difference in efficacy between the two groups after completion of treatment were also been counted.Result：After 2 monthes of treatment, the cure rate of treatment group was significantly higher than the control group, no efficiency was significantly lower than the control group, and the total effective rate was 90.0% which was significantly higher than the 73.3% of control group, he differences were statistically significant（P〈0.05）.After 2 monthes of treatment, the quantify symptom scores of pain, headache frequency and duration were all lower than those indexes of control group, the differences were statistically significant（P〈0.05）.Conclusion：The influence of Flunarizine combined with Tiapride for the patient with migraine is great, and it is more effective for the improvement of migraine symptoms.
出处
《中国医学创新》
CAS
2015年第3期118-120,共3页
Medical Innovation of China
